SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-17-001363
Filing Date
2017-05-02
Accepted
2017-05-02 17:18:41
Documents
4
Period of Report
2017-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 USANA HEALTH SCIENCES, INC. 8-K a51551851.htm 8-K 23175
2 EXHIBIT 99.1 a51551851ex99_1.htm EX-99.1 79978
3 EXHIBIT 99.2 a51551851ex99_2.htm EX-99.2 38410
4 logo.jpg GRAPHIC 12337
  Complete submission text file 0001157523-17-001363.txt   160126
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

IRS No.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35024 | Film No.: 17806167
SIC: 2833 Medicinal Chemicals & Botanical Products